What Are the Challenges of Diagnosing Renal Medullary Carcinoma?
https://vimeo.com/825344222 Renal medullary carcinoma (RMC) diagnosis may sometimes run into changes, but what are they? Expert Dr. Nizar Tannir explains what healthcare providers examine in RMC diagnosis, diagnosis challenges that can arise,…
How Is Renal Medullary Carcinoma Diagnosed?
https://vimeo.com/825344331 Renal medullary carcinoma (RMC) diagnosis involves testing that patients may need to follow up on. Expert Dr. Nizar Tannir explains common RMC symptoms, typical imaging tests that are involved, and advice…
What Are the Symptoms of Renal Medullary Carcinoma?
https://vimeo.com/825344448 What renal medullary carcinoma (RMC) symptoms do high-risk patients need to be aware of? Respected expert Dr. Nizar Tannir shares common symptoms that can signal RMC and advice for patients to…
What Is Renal Medullary Carcinoma?
https://vimeo.com/825344519 How is renal medullary carcinoma (RMC) defined? Expert Dr. Nizar Tannir explains RMC, who is most often impacted, and the risk factors for developing RMC. Dr. Nizar Tannir is a Professor…
Expert Advice | Shining a Light on Equitable AML Care
https://vimeo.com/825226188 While treatment options are improving, there are still many factors impacting equitable care for AML patients. Dr. Ann-Kathrin Eisfeld shares advice for improving research and clinical trials for underserved…
Emerging AML Treatment Classes Showing Promise
https://vimeo.com/825225712 What therapies are in development for acute myeloid leukemia (AML)? Dr. Ann-Kathrin Eisfeld discusses the latest research for AML treatment, including menin inhibitors and CAR T-cell therapy. Dr. Ann-Kathrin…
AML Treatment Approaches | Factors That Impact Options
https://vimeo.com/825224825 What factors are considered when choosing an AML treatment approach? Dr. Ann-Kathrin Eisfeld explains how shared decision-making comes into play when deciding on a therapy and reviews the options…
How Have Advances in Testing Impacted AML Care?
https://vimeo.com/825225812 Recent testing advances have dramatically improved care for AML patients. Dr. Ann-Kathrin Eisfeld discusses these improvements and why every AML patient should undergo in-depth molecular testing before making a…
Low-Risk Versus High-Risk AML
https://vimeo.com/825225958 How is AML risk determined, and how does it affect treatment options? Dr. Ann-Kathrin Eisfeld defines low-risk and high-risk AML and explains how this classification may predict disease response…
Essential Testing | Optimizing AML Care With Personalized Medicine
https://vimeo.com/825225431 Personalized acute myeloid leukemia (AML) care is becoming increasingly common, but how does it work? Dr. Ann-Kathrin Eisfeld defines personalized medicine and reviews the testing that should take place…
What Treatments Are Available for HER2-Positive Metastatic Breast Cancer?
https://vimeo.com/824278755 What are the differences between HR-positive and HER2-negative metastatic breast cancer? Expert Dr. Demetria Smith-Graziani gives a clear breakdown around the differences and encourages patients to ask what the available standard…
Pain Outcomes Among Black Women With Early Stage Breast Cancer After Mastectomy
https://vimeo.com/824278873 What do studies show about early breast cancer after mastectomy in Black women? Expert Dr. Demetria Smith-Graziani explains research into discrimination, trust, and pain outcomes in this patient group. Demetria Smith-Graziani,…